uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för medicinska vetenskaper, Reumatologi. Lulea Univ Technol, Dept Hlth Sci, Lulea, Sweden.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för medicinska vetenskaper, Klinisk farmakogenomik och osteoporos. Uppsala universitet, Science for Life Laboratory, SciLifeLab.ORCID-id: 0000-0002-2152-4343
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för medicinska vetenskaper, Klinisk farmakogenomik och osteoporos. Uppsala universitet, Science for Life Laboratory, SciLifeLab.ORCID-id: 0000-0003-3465-3280
Lulea Univ Technol, Dept Hlth Sci, Lulea, Sweden.
Vise andre og tillknytning
2019 (engelsk)Inngår i: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, ISSN 1756-1841, Vol. 22, nr 7, s. 1226-1232Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Aim: To assess predictors of alanine aminotransferase (ALT) elevation in methotrexate (MTX) treated rheumatoid arthritis (RA) patients, and to describe the monitoring of liver enzymes, including handling and outcome of elevated ALT.

Methods: All RA patients starting MTX in January, 2005 to April, 2013 at a rheumatology clinic, (Uppsala University Hospital, Sweden) were identified from electronic medical records. Clinical and laboratory data were obtained from medical records, supplemented by telephone interviews. Predictors for ALT >1.5x over the upper limit of normal (ULN) were identified by multiple regression analysis.

Results: The study comprised 213 RA patients starting MTX. During a mean follow-up of 4.3 years, 6288 ALT tests were performed; 7% of tests with ALT were >ULN. ALT >1.5x ULN was observed in 44 (21%) patients and the strongest predictor was a pre-treatment elevation of ALT (adjusted odds ratio = 6.8, 95% CI 2.2-20.5). Recurrent elevations occurred in 70% of patients who continued treatment, and the proportion was similar in those with and without interventions, for example MTX dose reduction (67% vs 73%, P = 0.43). Seven patients (3%) permanently stopped MTX due to ALT elevation, and two were eventually diagnosed with non-alcoholic fatty liver disease. No patient developed hepatic failure.

Conclusion: Only a small number of ALT tests performed during MTX therapy in RA capture an elevation. A pre-treatment elevation of ALT was the strongest predictor for early and recurrent ALT elevations during therapy. This study supports a more individualized approach to monitoring and handling of ALT elevations during MTX therapy in RA than recommended in current guidelines.

sted, utgiver, år, opplag, sider
WILEY , 2019. Vol. 22, nr 7, s. 1226-1232
Emneord [en]
liver toxicity, liver transaminases, methotrexate, non-alcoholic fatty liver disease, rheumatoid arthritis
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-391959DOI: 10.1111/1756-185X.13576ISI: 000476560400008PubMedID: 31012257OAI: oai:DiVA.org:uu-391959DiVA, id: diva2:1346197
Forskningsfinansiär
Swedish Research CouncilSwedish Heart Lung FoundationTilgjengelig fra: 2019-08-27 Laget: 2019-08-27 Sist oppdatert: 2019-08-27bibliografisk kontrollert

Open Access i DiVA

fulltekst(568 kB)119 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 568 kBChecksum SHA-512
f7a968bc5776e7ee07ddf8298ca51aff18c472f8354949157b24f60aa01bfd6d22582b11813b8896a85dcf74c6d64b095ec4acce0ef73de968b0f6af406c29bf
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Karlsson Sundbaum, JohannaEriksson, NiclasHallberg, PärWadelius, MiaBaecklund, Eva

Søk i DiVA

Av forfatter/redaktør
Karlsson Sundbaum, JohannaEriksson, NiclasHallberg, PärWadelius, MiaBaecklund, Eva
Av organisasjonen

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 119 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 119 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf